← Leaderboards
Frederick R Blattner
University Of Wisconsin Madison
$30,522,424
Attributed
$39,965,547
Total exposure
26
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,965,547 · 26
By mechanism
R44$28,306,857 · 13
R01$4,996,617 · 2
U01$4,434,948 · 1
R43$1,931,170 · 7
S10$252,955 · 1
R13$43,000 · 2
Top collaborators
- Charles F Landry14 shared
- David A Frisch4 shared
- Steven Joseph Darnell2 shared
- Timothy J Durfee2 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Charles F Landry$7,992,480
- Joseph P. Dillard$13,113,702
Others in their field
Top investigators on “Escherichia Coli”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Scott J Hultgren · Washington University$41,419,179
- John L Markley · University Of Wisconsin Madison$37,032,573
- Wilhelmus G. J. Hol · University Of Washington$31,124,692
- Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
- Peter D Karp · Sri International$27,278,650
Research focus
Escherichia ColiGenomeGenomicsProteinsProductionCostFermentationTechnologyGenesToxinAntibodiesPlasmidsPharmacologic SubstancePeriplasmPharmaceutical PreparationsEngineeringFlasksModificationRunningDesignVaccinesBiotechnologySafetyBacteria
Grant awards (60)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies$1,030,000
R44 · FY2025 · AI · contact PI
An improved low-endotoxin Clean Genome E. coli strain for production of biological products$806,101
R44 · FY2025 · GM
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies$1,020,000
R44 · FY2024 · AI · contact PI
An improved low-endotoxin Clean Genome E. coli strain for production of biological products$842,151
R44 · FY2024 · GM
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets$681,914
R44 · FY2024 · GM
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies$1,000,000
R44 · FY2023 · AI
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets$648,790
R44 · FY2023 · GM
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening$998,661
R44 · FY2022 · AI
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture$961,744
R44 · FY2022 · AI · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$1,000,000
R44 · FY2021 · AI · contact PI
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture$944,508
R44 · FY2021 · AI · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$1,000,000
R44 · FY2020 · AI · contact PI
Production of antibody therapeutic fragments by reduced genome E. coli in continuous culture$1,000,000
R44 · FY2020 · AI · contact PI
Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli$737,950
R44 · FY2020 · AI · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$1,000,000
R44 · FY2019 · AI · contact PI
Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli$911,189
R44 · FY2019 · AI · contact PI
Lysis-free extraction of biopharmaceuticals from the periplasm of Clean Genome E. coli$156,171
R44 · FY2019 · AI · contact PI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains$706,927
R44 · FY2018 · AI · contact PI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains$877,755
R44 · FY2017 · AI · contact PI
Characterization of a low mutation rate E. coli in extended fermentation$864,106
R44 · FY2017 · GM · contact PI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains$154,222
R44 · FY2017 · AI · contact PI
Characterization of a low mutation rate E. coli in extended fermentation$1,554,424
R44 · FY2016 · GM · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$728,655
R44 · FY2015 · AI · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$732,955
R44 · FY2014 · AI · contact PI
A protease-deficient, low mutation rate E. coli for biotherapeutics production$713,455
R44 · FY2014 · GM · contact PI
A protease-deficient, low mutation rate E. coli for biotherapeutics production$910,959
R44 · FY2013 · GM · contact PI
Characterization of a low mutation rate E. coli in extended fermentation$282,618
R43 · FY2013 · GM · contact PI
Innate Immune Protection by Clean Genome E. coli$737,476
R44 · FY2012 · AI · contact PI
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain$140,925
R43 · FY2012 · AI · contact PI
A protease-deficient, low mutation rate E. coli for biotherapeutics production$136,830
R44 · FY2012 · GM · contact PI
Innate Immune Protection by Clean Genome E. coli$995,989
R44 · FY2011 · AI · contact PI
Improved bacterial strains for therapeutic DNA and protein production$836,793
R44 · FY2010 · GM · contact PI
Innate Immune Protection by Clean Genome E. coli$139,981
R44 · FY2010 · AI · contact PI
Uniform length DNA for paired end nextgen sequencing via in vitro packaging$127,387
R43 · FY2010 · AI · contact PI
Improved bacterial strains for therapeutic DNA and protein production$989,190
R44 · FY2009 · GM · contact PI
Engineered revision of the E. coli Nissle 1917 Genome$141,037
R43 · FY2008 · GM · contact PI
Development of Advanced BAC Library Technology$119,850
R01 · FY2008 · HG · contact PI
Clean-Genome vaccines against biodefense agents$500,000
R43 · FY2007 · AI · contact PI
Development of Advanced BAC Library Technology$354,798
R01 · FY2007 · HG · contact PI
Improved bacterial strains for therapeutic DNA production$139,203
R43 · FY2007 · GM · contact PI
15th Annual International Conference on Microbial Genomics$19,000
R13 · FY2007 · AI · contact PI
Engineered Revision of E. coli for Production of DNA, Proteins and Metabolites$681,131
R44 · FY2006 · AI · contact PI
Clean-Genome vaccines against biodefense agents$500,000
R43 · FY2006 · AI · contact PI
Development of Advanced BAC Library Technology$360,450
R01 · FY2006 · HG · contact PI
Engineered Revision of E. coli for Production of DNA, Proteins and Metabolites$656,144
R44 · FY2005 · AI
Engineering E. coli for periplasmic protein production$312,132
R44 · FY2005 · GM
13th Annual International Conference on Microbial Genomes$24,000
R13 · FY2005 · AI
Engineering E. coli for periplasmic protein production$729,125
R44 · FY2004 · GM
BAC Library Production and Research Facility$349,639
R01 · FY2004 · HG
Engineering E. coli for periplasmic protein production$109,429
R44 · FY2004 · GM
Engineered Revision of the E. coli Genome for Production$100,000
R43 · FY2004 · AI
COMPLETE DISSECTION OF ESCHERICHIA COLI GENOME$407,400
R01 · FY2003 · GM
BAC Library Production and Research Facility$347,847
R01 · FY2003 · HG
A High Throughput Chip Analysis System for the U of Wisc$252,955
S10 · FY2003 · RR
COMPLETE DISSECTION OF ESCHERICHIA COLI GENOME$1,072,790
R01 · FY2002 · GM
BAC Library Production and Research Facility$350,000
R01 · FY2002 · HG
BACTERIAL PATHOGEN GENOME INITIATIVE$2,250,245
U01 · FY2001 · AI
COMPLETE DISSECTION OF ESCHERICHIA COLI GENOME$870,372
R01 · FY2001 · GM
BACTERIAL PATHOGEN GENOME INITIATIVE$2,184,703
U01 · FY2000 · AI
COMPLETE DISSECTION OF ESCHERICHIA COLI GENOME$763,471
R01 · FY2000 · GM